Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study

Journal of the American Society of Nephrology

Volumn 27, Issue 1, 2016, Pages 227-237

  Chonchol, Michel ^a   Greene, Tom ^b   Zhang, Yingying ^b   Hoofnagle, Andrew N ^c   Cheung, Alfred K ^d,e  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; C REACTIVE PROTEIN; CALCITRIOL; CALCIUM; FIBROBLAST GROWTH FACTOR 23; HIGH SENSITIVITY C REACTIVE PROTEIN; INTACT PARATHYROID HORMONE; INTERLEUKIN 6; PARATHYROID HORMONE; PHOSPHORUS; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; FIBROBLAST GROWTH FACTOR; VITAMIN D;

ADULT; AGE; ALBUMIN BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART DEATH; HOSPITALIZATION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; VITAMIN BLOOD LEVEL; BACTERIAL INFECTION; BLOOD; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; HEART DISEASE; HEMODIALYSIS; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL INSUFFICIENCY, CHRONIC;

BACTERIAL INFECTIONS; FEMALE; FIBROBLAST GROWTH FACTORS; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; VITAMIN D;

EID: 84954426824     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014101009     Document Type: Article

References (42)

1. Cheung AK, SarnakMJ, Yan G, Dwyer JT, Heyka RJ, RoccoMV, Teehan BP, Levey AS: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58: 353-362, 2000
2. AllonM: Evidence-based cardiology in hemodialysis patients.JAmSoc Nephrol 24: 1934-1943, 2013
3. Foley RN, Guo H, Snyder JJ, Gilbertson DT, Collins AJ: Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol 15: 1038-1045, 2004
4. AllonM, RadevaM, Bailey J, Beddhu S, Butterly D, Coyne DW, Depner TA, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ; HEMO Study Group: The spectrum of infection-related morbidity in hospitalized haemodialysis patients.NephrolDial Transplant 20: 1180-1186, 2005
5. Chavers BM, Solid CA, Gilbertson DT, Collins AJ: Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States.JAmSocNephrol 18: 952-959, 2007
6. Evenepoel P, Rodriguez M, Ketteler M: Laboratory abnormalities in CKD-MBD: Markers, predictors, or mediators of disease? Semin Nephrol 34: 151-163, 2014
7. Holick MF: Vitamin D deficiency. N Engl J Med 357: 266-281, 2007
8. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R: Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72: 1004-1013, 2007
9. Drechsler C, Verduijn M, Pilz S, Dekker FW, Krediet RT, Ritz E,Wanner C, Boeschoten EW, Brandenburg V; NECOSAD Study Group: Vitamin D status and clinical outcomes in incident dialysis patients: Results from the NECOSAD study. Nephrol Dial Transplant 26: 1024-1032, 2011
10. Block GA, Klassen PS, Lazarus JM,Ofsthun N, Lowrie EG, ChertowGM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004
11. Plantinga LC, Fink NE, Melamed ML, Briggs WA, Powe NR, Jaar BG: Serum phosphate levels and risk of infection in incident dialysis patients. Clin J Am Soc Nephrol 3: 1398-1406, 2008
12. Chonchol M, Kendrick J, Targher G: Extra-skeletal effects of Vitamin D deficiency in chronic kidney disease. Ann Med 43: 273-282, 2011
13. GunvilleCF,Mourani PM, GindeAA: The role of vitaminDin prevention and treatment of infection. InflammAllergy Drug Targets 12: 239-245, 2013
14. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL: Toll-like receptor triggering of a Vitamin D -mediated human antimicrobial response. Science 311: 1770-1773, 2006
15. Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, Kato S, Ogata E, Segawa H, Miyamoto K, Fukushima N: Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 280: 2543-2549, 2005
16. Stubbs J, Liu S, Quarles LD: Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Semin Dial 20: 302-308, 2007
17. Gutiérrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R,Wang TJ, deFilippi C,Wolf M: Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119: 2545-2552, 2009
18. Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, GutiérrezOM, Steigerwalt S, He J, Schwartz S, Lo J,Ojo A, Sondheimer J, Hsu CY, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M; Chronic Renal Insufficiency Cohort (CRIC) Study Group: Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 305: 2432-2439, 2011
19. Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Chonchol M; HOST Investigators: FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol 22: 1913-1922, 2011
20. Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M: Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl JMed 359: 584-592, 2008
21. Bacchetta J, Salusky IB, Hewison M: Beyond mineral metabolism, is there an interplay between FGF23 and Vitamin D in innate immunity? Pediatr Nephrol 28: 577-582, 2013
22. Bacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling-Perry K, Gales B, Adams JS, Salusky IB, Hewison M: Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes. J Bone Miner Res 28: 46-55, 2013
23. Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, HeimbürgerO, Lindholm B, Bergström J: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13[Suppl 1]: S28-S36, 2002
24. van Tellingen A, GrootemanMP, SchoorlM, Bartels PC, SchoorlM, van der Ploeg T, ter Wee PM, Nubé MJ: Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients. Kidney Int 62: 632-638, 2002
25. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R; Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
26. Levin A, Bakris GL,MolitchM, SmuldersM, Tian J,Williams LA, Andress DL: Prevalence of abnormal serum Vitamin D , PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int 71: 31-38, 2007
27. Chonchol M, Scragg R: 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 71: 134-139, 2007
28. Duso AS, Brown AJ, Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol 289: F8-F28, 2005
29. Ritter CS, Armbrecht HJ, Slatopolsky E, Brown AJ: 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int 70: 654-659, 2006
30. Holick MF: Sunlight and Vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80[Suppl]: 1678S-1688S, 2004
31. Stumpf WE, Sar M, Reid FA, Tanaka Y, DeLuca HF: Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 206: 1188-1190, 1979
32. van Etten E, Stoffels K, Gysemans C, Mathieu C, Overbergh L: Regulation of Vitamin D homeostasis: Implications for the immune system. Nutr Rev 66[Suppl 2]: S125-S134, 2008
33. Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR, Tangpricha V: Alterations in Vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 7: 28-36, 2009
34. Ginde AA, Mansbach JM, Camargo CA Jr: Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 169: 384-390, 2009
35. Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamäki H, Ylikomi T: An association of serumvitamin D concentrations,40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 86: 714-717, 2007
36. Holick MF: Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis.AmJClinNutr 79: 362-371, 2004
37. LondonGM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F: Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18: 613-620, 2007
38. Hsu HJ, Wu MS: Fibroblast growth factor 23: A possible cause of left ventricular hypertrophy in hemodialysis patients. Am J Med Sci 337: 116-122, 2009
39. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P,Morales A, Scialla J, FischerM, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, DiMarco GS, Reuter S, Kentrup D, Tiemann K, BrandM, Hill JA,MoeOW, Kuro-OM, Kusek JW, Keane MG, Wolf M: FGF23 induces left ventricular hypertrophy. J Clin Invest 121: 4393-4408, 2011
40. Lissner D, Mason RS, Posen S: Stability of Vitamin D metabolites in human blood serum and plasma. Clin Chem 27: 773-774, 1981
41. Phinney KW: Development of a standard reference material for Vitamin D in serum. Am J Clin Nutr 88: 511S-512S, 2008
42. Imel EA, PeacockM, Pitukcheewanont P, Heller HJ,Ward LM, Shulman D, Kassem M, Rackoff P, Zimering M, Dalkin A, Drobny E, Colussi G, Shaker JL, Hoogendoorn EH, Hui SL, EconsMJ: Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab 91: 2055-2061, 2006